Abstract
The high defect and unstable of defects the company in 2017 amounted to 0.27% while the amount allowed by this company was 0.10%. In This research was carried out in a Pharmaceutical Industry with the purpose of reducing the product spots drug tablets, the research method uses the DMAIC stages Define, Measure, Analyze, Improve and Control. The tools used are SIPOC diagrams, pareto diagrams, P charts, minitabs to calculate sigma levels and improvment with FMEA. The number of reject spots for tablets in 2018 was 0.28% and the sigma level was 4.63, then after analysis and DMAIC the reject rate was reduced to 0.0081% and sigma level 5.45.
Export citation and abstract BibTeX RIS
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.